Sean Bohen
2023
In 2023, Sean Bohen earned a total compensation of $3.2M as President and Chief Executive Officer at Olema Pharmaceuticals, a 47% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $489,000 |
|---|---|
| Option Awards | $2,002,000 |
| Salary | $647,000 |
| Other | $14,370 |
| Total | $3,152,370 |
Bohen received $2M in option awards, accounting for 64% of the total pay in 2023.
Bohen also received $489K in non-equity incentive plan, $647K in salary and $14.4K in other compensation.
Rankings
In 2023, Sean Bohen's compensation ranked 280th out of 2,978 executives tracked by ExecPay. In other words, Bohen earned more than 90.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 280 out of 2,978 | 91st |
Division Manufacturing | 151 out of 1,637 | 91st |
Major group Chemicals And Allied Products | 102 out of 906 | 89th |
Industry group Drugs | 99 out of 869 | 89th |
Industry Pharmaceutical Preparations | 63 out of 627 | 90th |
Source: SEC filing on April 26, 2024.
Bohen's colleagues
We found three more compensation records of executives who worked with Sean Bohen at Olema Pharmaceuticals in 2023.